A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
Pulmonary Fibrosis Pulmonary Hypertension PF Inhaled Nitric Oxide iNO Long Term Oxygen Therapy Oxygen REBUILD INOpulse pulsed inhaled nitric oxide fILD fibrotic interstitial lung disease portable pulsed inhaled nitric oxide Hypertension, Pulmonary Hypertension Fibrosis INOpulse® Open Label Extension Inhaled Nitric Oxide (iNO)
Lead Scientist at UCSF
- Vijay Balasubramanian, MD
Clinical Professor of Medicine, UCSF Medical Director of Pulmonary Hypertension-Community Regional Medical Center Vijay Balasubramanian, M.D., specializes in pulmonary disease. He is board certified in Internal Medicine. His residency and fellowship training were completed at the Medical College of Wisconsin.